Asset Details
Do you wish to reserve the book?
Albumin excretion in diabetic patients in the setting of acute myocardial infarction: association with 3-year mortality
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Albumin excretion in diabetic patients in the setting of acute myocardial infarction: association with 3-year mortality
Do you wish to request the book?
Albumin excretion in diabetic patients in the setting of acute myocardial infarction: association with 3-year mortality
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Albumin excretion in diabetic patients in the setting of acute myocardial infarction: association with 3-year mortality
2004
Overview
Diabetes mellitus is associated with increased mortality in subjects with acute myocardial infarction (AMI). We aimed to estimate the risk of mortality in AMI patients with and without diabetes using the urinary albumin : creatinine ratio (ACR).
This is a prospective study of 121 consecutive, non-selected diabetic AMI patients, 121 age- and sex-matched non-diabetic AMI patients and 61 diabetic non-AMI outpatients as control subjects. All data were obtained during the first 7 days of hospitalisation and each AMI patient was followed for a period of exactly 3 years. Baseline ACR RIA measurements were made on the 1st, 3rd and 7th days of admission.
Adjusted ACR values were significantly higher in the diabetic AMI patients than in the diabetic control outpatients ( p<0.0001), and a significant difference was observed between the weekly ACR slopes for these two groups ( p<0.0001). Microalbuminuria was more prevalent in the diabetic AMI patients than in the non-diabetic AMI patients on the 1st day (62% vs 46%, p=0.01) and 3rd day (41% vs 29%, p=0.04). Among the AMI patients with normoalbuminuria (ACR <30 microg/mg), the mortality rate was 11.6% for the patients without diabetes and 33.8% for those with diabetes ( p=0.001). The mortality rate was much higher among the AMI patients with microalbuminuria (ACR >/=30 microg/mg) and similar for the diabetic (68.0%) and non-diabetic patients (74.3%). In a multivariable Cox model, ACR ( p<0.0001) and diabetes status ( p=0.01) were associated with adverse outcome even when several other clinical variables were included in the model. Furthermore, a negative interaction was found between diabetes and ACR ( p=0.01).
Microalbuminuria frequently occurs in diabetic and non-diabetic AMI patients during the first 3 days of admission to hospital and can be used to identify subjects at high risk of mortality.
Publisher
Springer,Springer Nature B.V
Subject
/ Biological and medical sciences
/ Diabetes Mellitus, Type 1 - mortality
/ Diabetes Mellitus, Type 1 - urine
/ Diabetes Mellitus, Type 2 - mortality
/ Diabetes Mellitus, Type 2 - urine
/ Diabetes. Impaired glucose tolerance
/ Diabetic Angiopathies - mortality
/ Diabetic Angiopathies - urine
/ Endocrine pancreas. Apud cells (diseases)
/ Female
/ Heart
/ Humans
/ Male
/ Myocardial Infarction - mortality
